Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma. Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback